Plan Les Ouates News Today

Regulatory News: GeNeuro , a biopharmaceutical company focused on halting the progression of neurodegenerative and autoimmune diseases such as multiple sclerosis , amyotrophic lateral sclerosis ...

Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases...

Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseasesGENEVA, May 22, 2024 (GLOBE NEWSWIRE) -- Antion Biosciences (Antion), a Geneva-based cell and gene therapy company

Switzerland-based ProtonMail has found itself in the crosshairs of the Indian government as it seeks to block the platform. The encrypted email service providers users range from tech executives to actors on the dark web due to the safety it assures. Will blocking solve the problem?

The wait lists have been legendary – if you can get onto one. But prices are softening and there are some things you can do.

For Proton VPN review, we tested its top features and explored how the user interface fares on different devices. Find out if it's worth it!

A Swiss joint stock company with share capital of 1,249,951.40 Swiss francs Registered office: 3 chemin du Pré-Fleuri - 1228 Plan-Les-Ouates - Geneva -...

GENEVA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, is ple...

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – July 13, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women's health, today

The Japanese public offered a very warm welcome to the Patek Philippe grand exhibition “Watch Art” Tokyo 2023